Trial Profile

The Effects of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals (NAUTICAL)

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 18 Jul 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sacubitril/valsartan (Primary) ; Valsartan
Indications Insulin resistance
Focus Therapeutic Use
Acronyms NAUTICAL

Most Recent Events

20 Mar 2023 Planned End Date changed from 30 Aug 2026 to 31 May 2027.
20 Mar 2023 Planned primary completion date changed from 30 Aug 2026 to 31 Dec 2026.
26 May 2021 The study protocol amended to include adult healthy volunteers self-identified race or ethnicity as African-American or Black. Study endpoints, inclusion exclusion criteria, and treatment were updated accordingly. The planned patient number increased from 80 to 200.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com